We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PJT icon
276
PJT Partners
PJT
$4.26B
$13.7M 0.11%
+256,846
New +$14.1M
GOOG icon
277
Alphabet (Google) Class C
GOOG
$4.11T
$13.6M 0.11%
+244,240
New +$13.2M
SPGI icon
278
S&P Global
SPGI
$124B
$13.6M 0.11%
66,700
-8,450
-11% -$1.67M
RDS.B
279
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$13.6M 0.11%
186,815
-45,794
-20% -$3.3M
XYL icon
280
Xylem
XYL
$28.5B
$13.5M 0.11%
200,900
+7,850
+4% +$570K
DD icon
281
DuPont de Nemours
DD
$18.6B
$13.4M 0.11%
80,341
-1,377
-2% -$231K
OC icon
282
Owens Corning
OC
$11B
$13.4M 0.11%
210,775
+86,175
+69% +$5.95M
JKHY icon
283
Jack Henry & Associates
JKHY
$11.4B
$13.2M 0.1%
101,350
-21,055
-17% -$2.61M
EVRG icon
284
Evergy
EVRG
$19.4B
$13M 0.1%
+232,098
New +$12.4M
SRE icon
285
Sempra
SRE
$58.1B
$13M 0.1%
223,840
-3,834
-2% -$210K
BMRN icon
286
BioMarin Pharmaceuticals
BMRN
$11.9B
$12.9M 0.1%
137,275
-142,223
-51% -$12.5M
SAP icon
287
SAP
SAP
$215B
$12.9M 0.1%
111,616
-24,055
-18% -$2.72M
PPLI
288
People Inc
PPLI
$3.12B
$12.9M 0.1%
473,092
+107,572
+29% +$2.95M
MO icon
289
Altria Group
MO
$125B
$12.7M 0.1%
223,198
-3,824
-2% -$221K
NSC icon
290
Norfolk Southern
NSC
$75.4B
$12.6M 0.1%
83,550
-6,550
-7% -$957K
FISV
291
Fiserv Inc
FISV
$29.7B
$12.5M 0.1%
168,925
-10,869
-6% -$789K
PLD icon
292
Prologis
PLD
$136B
$12.4M 0.1%
189,331
-3,244
-2% -$209K
MMM icon
293
3M
MMM
$91.8B
$12.4M 0.1%
75,309
-1,289
-2% -$220K
NVS icon
294
Novartis
NVS
$302B
$12.4M 0.1%
182,646
+26,344
+17% +$1.82M
PBYI icon
295
Puma Biotechnology
PBYI
$398M
$12.3M 0.1%
207,820
RHI icon
296
Robert Half
RHI
$4.11B
$12.2M 0.1%
187,075
+17,975
+11% +$1.14M
CE icon
297
Celanese
CE
$4.82B
$12.1M 0.1%
108,825
-13,850
-11% -$1.53M
MA icon
298
Mastercard
MA
$498B
$12.1M 0.09%
+61,330
New +$11.5M
MCD icon
299
McDonald's
MCD
$193B
$12M 0.09%
76,672
-1,313
-2% -$213K
TXRH icon
300
Texas Roadhouse
TXRH
$13.7B
$11.8M 0.09%
179,844
+42,700
+31% +$2.68M

Similar funds

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.